@neobiotechlabs/neobiotech-dev-agent-codex 0.1.39
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- package/.codex-plugin/plugin.json +36 -0
- package/.mcp.json +20 -0
- package/data/cyber_sec.png +0 -0
- package/data/hazard_panel.png +0 -0
- package/data/review-criteria.md +185 -0
- package/data/risk_score.png +0 -0
- package/dist/build/plantuml-1.2026.1.jar +0 -0
- package/dist/data/Courier-Bold.afm +342 -0
- package/dist/data/Courier-BoldOblique.afm +342 -0
- package/dist/data/Courier-Oblique.afm +342 -0
- package/dist/data/Courier.afm +342 -0
- package/dist/data/Helvetica-Bold.afm +2827 -0
- package/dist/data/Helvetica-BoldOblique.afm +2827 -0
- package/dist/data/Helvetica-Oblique.afm +3051 -0
- package/dist/data/Helvetica.afm +3051 -0
- package/dist/data/Symbol.afm +213 -0
- package/dist/data/Times-Bold.afm +2588 -0
- package/dist/data/Times-BoldItalic.afm +2384 -0
- package/dist/data/Times-Italic.afm +2667 -0
- package/dist/data/Times-Roman.afm +2419 -0
- package/dist/data/ZapfDingbats.afm +225 -0
- package/dist/data/sRGB_IEC61966_2_1.icc +0 -0
- package/dist/doctor.js +15106 -0
- package/dist/doctor.js.map +1 -0
- package/dist/fonts/LICENSE.txt +94 -0
- package/dist/fonts/Pretendard-Bold.ttf +0 -0
- package/dist/fonts/Pretendard-Regular.ttf +0 -0
- package/dist/index.js +185999 -0
- package/dist/index.js.map +1 -0
- package/dist/setup-codex.js +164 -0
- package/dist/setup-codex.js.map +1 -0
- package/package.json +34 -0
- package/skills/doc-render/SKILL.md +84 -0
- package/skills/role-document-content-reviewer/SKILL.md +68 -0
- package/skills/role-mdr-cybersecurity-reviewer/SKILL.md +47 -0
- package/skills/role-mdr-regulatory-architect/SKILL.md +48 -0
- package/skills/role-requirement-coverage-tracker/SKILL.md +108 -0
- package/skills/role-sw-architect/SKILL.md +61 -0
- package/vendor/dev-docs-templates/templates/dev_docs/plan_template.md +104 -0
- package/vendor/dev-docs-templates/templates/dev_docs/prd_template.md +110 -0
- package/vendor/dev-docs-templates/templates/dev_docs/spec_template.md +81 -0
- package/vendor/dev-docs-templates/templates/dev_docs/tasks_template.md +122 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/checklist-clinical-evaluation.md +81 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/checklist-gspr-mdr.md +403 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/clinical-evaluation-report.md +492 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/instructions-for-use.md +132 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/literature-evaluation-table.md +15 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/mdr-declaration-of-conformity.md +75 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/post-market-clinical-follow-up-plan.md +162 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/post-market-surveillance-plan.md +175 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/risk-management-cybersecurity-checklist.md +67 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/risk-management-report.md +111 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/CA/usability-evaluation-report.md +70 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/EA/clinical-evaluation-plan.md +154 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/EA/list-of-hazard-related-use-scenarios.md +34 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/EA/risk-table-fmea.md +155 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/EA/software-architecture-description.md +307 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/EA/software-detailed-design.md +321 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/EA/software-requirements-list.md +156 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/EA/soup-list.md +82 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/EA/usability-evaluation-plan.md +103 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/ER/global/bug-fixes-documentation-list.md +35 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/ER/global/change-evaluation-list.md +100 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/ER/global/list-of-known-anomalies.md +29 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/ER/sprint/algorithm-validation-report.md +170 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/ER/sprint/checklist-software-release.md +52 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/ER/sprint/checklist-software-requirements-review.md +50 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/ER/sprint/software-architecture-checklist.md +41 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/ER/sprint/software-system-test-plan.md +155 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/ER/sprint/usability-evaluation-protocol.md +63 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/PA/configuration-management-plan.md +112 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/PA/intended-use.md +116 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/PA/mdr-classification-document.md +114 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/PA/risk-management-plan.md +198 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/PA/security-management-plan.md +101 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/PA/software-development-maintenance-plan.md +213 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/PA/system-requirements-spec.md +182 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/global/information_security/information-security-controls.md +966 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/global/information_security/information-security-policy-and-scope.md +99 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/global/qms/quality-manual-policy-objectives.md +187 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/global/qms/sop-capa.md +112 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/global/qms/sop-change-management.md +128 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/global/qms/sop-clinical-evaluation.md +102 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/global/qms/sop-feedback-management.md +140 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/global/qms/sop-integrated-software-development.md +361 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/global/qms/sop-post-market-surveillance.md +159 -0
- package/vendor/dev-docs-templates/templates/mdr_docs/global/qms/sop-software-problem-resolution.md +99 -0
|
@@ -0,0 +1,36 @@
|
|
|
1
|
+
{
|
|
2
|
+
"name": "neobiotech-dev-agent",
|
|
3
|
+
"version": "0.1.39",
|
|
4
|
+
"description": "의료기기 SW 규제 개발 자동화",
|
|
5
|
+
"author": {
|
|
6
|
+
"name": "NeoBiotech"
|
|
7
|
+
},
|
|
8
|
+
"homepage": "https://github.com/NeobiotechLabs/jira-mcp-server",
|
|
9
|
+
"repository": "https://github.com/NeobiotechLabs/jira-mcp-server",
|
|
10
|
+
"license": "MIT",
|
|
11
|
+
"keywords": [
|
|
12
|
+
"medical-device",
|
|
13
|
+
"iec-62304",
|
|
14
|
+
"mdr",
|
|
15
|
+
"jira",
|
|
16
|
+
"confluence"
|
|
17
|
+
],
|
|
18
|
+
"skills": "./skills/",
|
|
19
|
+
"mcpServers": "./.mcp.json",
|
|
20
|
+
"interface": {
|
|
21
|
+
"displayName": "NeoBiotech Dev Agent (MedDev)",
|
|
22
|
+
"shortDescription": "의료기기 SW 규제 개발 자동화",
|
|
23
|
+
"longDescription": "Jira·Confluence·Risk·CVSS·Xray·IEC 62304/62366·MDR·문서 렌더 workflow를 제공한다.",
|
|
24
|
+
"developerName": "NeoBiotech",
|
|
25
|
+
"category": "Productivity",
|
|
26
|
+
"capabilities": [
|
|
27
|
+
"Interactive",
|
|
28
|
+
"Write"
|
|
29
|
+
],
|
|
30
|
+
"defaultPrompt": [
|
|
31
|
+
"Jira 프로젝트 상태와 다음 규제 개발 작업을 정리해줘.",
|
|
32
|
+
"MDR 문서를 검토하고 누락된 증거를 찾아줘.",
|
|
33
|
+
"티켓에서 규제 문서 초안을 만들어줘."
|
|
34
|
+
]
|
|
35
|
+
}
|
|
36
|
+
}
|
package/.mcp.json
ADDED
|
@@ -0,0 +1,20 @@
|
|
|
1
|
+
{
|
|
2
|
+
"mcpServers": {
|
|
3
|
+
"neobiotech-dev-agent": {
|
|
4
|
+
"command": "node",
|
|
5
|
+
"args": [
|
|
6
|
+
"${PLUGIN_ROOT}/dist/index.js"
|
|
7
|
+
],
|
|
8
|
+
"env": {
|
|
9
|
+
"JIRA_URL": "${JIRA_URL}",
|
|
10
|
+
"JIRA_EMAIL": "${JIRA_EMAIL}",
|
|
11
|
+
"JIRA_API_TOKEN": "${JIRA_API_TOKEN}",
|
|
12
|
+
"XRAY_CLIENT_ID": "${XRAY_CLIENT_ID:-}",
|
|
13
|
+
"XRAY_CLIENT_SECRET": "${XRAY_CLIENT_SECRET:-}",
|
|
14
|
+
"RISK_PLUGIN_ENDPOINT": "${RISK_PLUGIN_ENDPOINT:-}",
|
|
15
|
+
"RISK_PLUGIN_AUTH_TOKEN": "${RISK_PLUGIN_AUTH_TOKEN:-}",
|
|
16
|
+
"RISK_PLUGIN_AUTHOR": "${RISK_PLUGIN_AUTHOR:-}"
|
|
17
|
+
}
|
|
18
|
+
}
|
|
19
|
+
}
|
|
20
|
+
}
|
|
Binary file
|
|
Binary file
|
|
@@ -0,0 +1,185 @@
|
|
|
1
|
+
# Review Criteria — content/coverage 평가 기준 (layer ②)
|
|
2
|
+
|
|
3
|
+
- **용도**: 신규 subagent 2종(`document-content-reviewer`, `requirement-coverage-tracker`)이 참조하는 layer ② 평가 기준.
|
|
4
|
+
- **기원**: 2026-07-16. 기존 `src/tools/expert-checklists.ts`(regulatory·cybersecurity 체크리스트, TS 상수)와 동일한 layer지만 **형식이 .md 자유 텍스트** — 이 영역은 LLM 자유 평가라 인터페이스·판정 함수보다 기준 명시가 본질.
|
|
5
|
+
- **참조 우선순위**:
|
|
6
|
+
1. 본 파일
|
|
7
|
+
2. `src/tools/annex-ii-template.ts` — MDR Annex II 섹션 9개 (`DocSection.id`, `matchKeywords`, `expectedSubTypes`)
|
|
8
|
+
3. `vendor/dev-docs-templates/templates/` (submodule, git checkout 필요) — issuetype별 템플릿
|
|
9
|
+
4. `src/tools/expert-checklists.ts` — 표준 준수 체크리스트 (MDR/IEC 81001-5-1/AAMI)
|
|
10
|
+
|
|
11
|
+
> 본 파일은 **평가의 객관적 기준만** 명시한다. **verdict 적용·soft/hard 구분은 에이전트 본문이 책임**.
|
|
12
|
+
|
|
13
|
+
---
|
|
14
|
+
|
|
15
|
+
## 1. Placeholder 패턴 (placeholder 잔존 검사)
|
|
16
|
+
|
|
17
|
+
문서 body에 남아 **수정되지 않은 채로 publish되면 안 되는** 패턴. LLM은 description·첨부 본문을 Grep하거나 Read로 확인해 다음 패턴 잔존 시 WARN, 빈칸이 본문 의도였으면 PASS.
|
|
18
|
+
|
|
19
|
+
| 패턴 | 의미 (작성 중 placeholder 의도) | 잔존 시 verdict |
|
|
20
|
+
|------|--------------------------------|----------------|
|
|
21
|
+
| `{{...}}` | Mustache / handlebars | WARN |
|
|
22
|
+
| `<...>` 꺾쇠 변수 (`{TICKET_ID}` 등 메타 변수 제외) | 작성 중 삽입 가이드 | WARN |
|
|
23
|
+
| `[여기에 ... 기재]` / `[content to be filled]` | 자유 텍스트 placeholder | WARN (영문/한글 모두) |
|
|
24
|
+
| `_____` (5연속 이상 underscore) | 빈칸 | WARN |
|
|
25
|
+
| `TODO:` / `FIXME:` / `XXX:` | 미완료 마커 | severity에 따라 WARN/FAIL |
|
|
26
|
+
| `Lorem ipsum` / `placeholder text` | 미작성 본문 placeholder | FAIL |
|
|
27
|
+
| `[Document content to be filled]` 등 `annex-ii-template.ts`가 생성하는 기본값 | `doc_create_from_template` 직후 미작성 상태 | FAIL (단, template 발급 직후 24h 내 작성 예정이면 WARN) |
|
|
28
|
+
|
|
29
|
+
> **예외**: `{TICKET_ID}`, `{DATE}`, `{FEATURE_SLUG}`, `{REPORTER}` 등 `src/utils/doc-render.ts`가 **치환하는 메타 변수**는 placeholder가 아니라 정상. 잔존 시 `unresolved`로 FAIL.
|
|
30
|
+
|
|
31
|
+
---
|
|
32
|
+
|
|
33
|
+
## 2. Template 섹션 목록 (issuetype → 필수 헤더·하위 항목)
|
|
34
|
+
|
|
35
|
+
LLM은 description 본문에서 Markdown 헤더 (`#`, `##`)·리스트·표를 추출해 아래 섹션의 존재·순서·내용 깊이를 평가. **`vendor/dev-docs-templates/`** submodule이 체크아웃돼 있으면 그 템플릿 본문을 Read해 직접 비교, 미체크아웃이면 정규식으로 헤더만 검사.
|
|
36
|
+
|
|
37
|
+
### 2.1 dev_docs (PRD/Spec/Plan/Tasks) — `src/utils/doc-render.ts` `t='prd'|'spec'|'plan'|'tasks'`
|
|
38
|
+
|
|
39
|
+
| issuetype | 템플릿 path | 필수 헤더 (최소) |
|
|
40
|
+
|-----------|-------------|------------------|
|
|
41
|
+
| Story / PRD | `vendor/dev-docs-templates/templates/dev_docs/prd_template.md` | `## Problem Statement` · `## Goals` · `## Non-Goals` · `## User Stories` · `## Acceptance Criteria` · `## Risks & Open Questions` |
|
|
42
|
+
| Spec | `vendor/.../dev_docs/spec_template.md` | `## Overview` · `## Detailed Behavior` · `## API/Interface` · `## Edge Cases` · `## Test Plan` |
|
|
43
|
+
| Plan | `vendor/.../dev_docs/plan_template.md` | `## Phases` · `## Dependencies` · `## Risk Mitigation` · `## Exit Criteria` |
|
|
44
|
+
| Tasks | `vendor/.../dev_docs/tasks_template.md` | 우선순위·phase·완료조건 명시 — issue list 형식 권장 |
|
|
45
|
+
|
|
46
|
+
### 2.2 MDR Annex II (Document, integrated root) — `src/tools/annex-ii-template.ts`
|
|
47
|
+
|
|
48
|
+
9개 섹션 (DocSection.id). 각 섹션의 `expectedSubTypes`(있으면) 존재도 확인.
|
|
49
|
+
|
|
50
|
+
| DocSection.id | issuetype 권장 | title (KO) |
|
|
51
|
+
|---------------|----------------|------------|
|
|
52
|
+
| `device-description` | Document + Intended Use / Classification | 기기 설명 및 사양 |
|
|
53
|
+
| `manufacturer-info` | Document | 제조자 정보 |
|
|
54
|
+
| `design-manufacturing` | Document + Architecture / Detailed Design | 설계 및 제조 정보 |
|
|
55
|
+
| `gspr` | Document + GSPR mapping | GSPR 준수성 |
|
|
56
|
+
| `risk-management` | Document + Hazard / Requirement | 리스크 관리 |
|
|
57
|
+
| `verification-validation` | Document + Test / Test Execution | 검증 및 검증 (V&V) |
|
|
58
|
+
| `usability` | Document + Use Specification / Scenario / Validation | 사용성 공학 |
|
|
59
|
+
| `pms` | Document | 시판후 감시 |
|
|
60
|
+
| `ce` | Document | CE 마킹 및 준수 선언 |
|
|
61
|
+
|
|
62
|
+
> 자세한 matchKeywords·expectedSubTypes·requireApproval은 `src/tools/annex-ii-template.ts` 직접 참조 권장 (canonical).
|
|
63
|
+
|
|
64
|
+
### 2.3 MDR gate documents — `src/utils/doc-render.ts` `t='system_requirements_spec' | ...`
|
|
65
|
+
|
|
66
|
+
| doc_render template | 필수 헤더 (최소) | 비고 |
|
|
67
|
+
|--------------------|------------------|------|
|
|
68
|
+
| `intended_use` | 사용 목적 (intended purpose) · 환자군 · 사용 환경 · 사용자에 대한 의도 | IEC 62366-1 use_spec content와 정합 |
|
|
69
|
+
| `system_requirements_spec` (SyRS) | 시스템 식별 · 시스템 기능 · 외부 인터페이스 · 시스템 성능 · 설계 제약 | PA gate 핵심 |
|
|
70
|
+
| `risk_management_plan` | 정책 · 활동 · 책임 · 절차 · 검토 | ISO 14971 정합 |
|
|
71
|
+
| `mdr_classification_document` | 분류 규칙 application · 최종 클래스 · 사유 | MDR Annex VIII |
|
|
72
|
+
| `software_development_maintenance_plan` | lifecycle model · 명세 · 구현 · 검증 · 유지보수 · 리스크 관리 활동 | IEC 62304 |
|
|
73
|
+
| `software_requirements_list` (SRS) | 각 requirement별로 id · description · source · verification method | EA gate 핵심 |
|
|
74
|
+
| `software_architecture_description` (SAD) | 컴포넌트 식별 · 인터페이스 · 아키텍처 결정 · 의존성 | EA gate |
|
|
75
|
+
| `risk_table_fmea` | hazard × severity × occurrence × mitigations | EA gate |
|
|
76
|
+
| `soup_list` | SOUP 식별 · 라이선스 · 검증 방법 · 알려진 anomaly | EA gate |
|
|
77
|
+
| `usability_evaluation_plan` | 사용자 프로파일 · 시나리오 요약 · 검증 방법 | IEC 62366-1 |
|
|
78
|
+
| `clinical_evaluation_plan` | intended purpose와 동일 · 임상 문헌 검색 전략 · endpoint | MDR Art.61 |
|
|
79
|
+
| `list_of_hazard_related_use_scenarios` | scenario × hazard × harm × mitigations | EA gate |
|
|
80
|
+
|
|
81
|
+
> `template_version`은 `src/utils/doc-render.ts` `TEMPLATE_VERSION` (단일 진실 원천). 평가 시 `unresolved` placeholder 잔존과 함께 확인.
|
|
82
|
+
|
|
83
|
+
### 2.4 Use Specification / Hazard / Risk — IEC 62366-1, ISO 14971
|
|
84
|
+
|
|
85
|
+
| issuetype | 필수 헤더 | 표준 |
|
|
86
|
+
|-----------|----------|------|
|
|
87
|
+
| Use Specification | 사용자 프로파일 · 사용 환경 · intended use | IEC 62366-1 §5.1 |
|
|
88
|
+
| Use Scenario | summary · description · type(normal/abnormal) · frequency | IEC 62366-1 §5.3 |
|
|
89
|
+
| Usability Validation | method · result · evidence · participants | IEC 62366-1 §5.6 |
|
|
90
|
+
| Hazard | summary · description · harm · severity · P1 · P2 · source keys | ISO 14971 |
|
|
91
|
+
| Risk Report | risk policy · methodology · acceptability criteria | ISO 14971 |
|
|
92
|
+
|
|
93
|
+
---
|
|
94
|
+
|
|
95
|
+
## 3. Chain 규칙 (섹션 간 정합성)
|
|
96
|
+
|
|
97
|
+
LLM은 description + links를 함께 보고 다음 chain의 **링크 단절**(technical) 또는 **내용 모순**(semantic)을 평가. technical 검증은 layer-1 툴(`traceability_check`)에 위임, semantic 평가는 content-reviewer가 LLM으로.
|
|
98
|
+
|
|
99
|
+
### 3.1 의료기기 핵심 chain
|
|
100
|
+
|
|
101
|
+
```
|
|
102
|
+
Intended Use (Document)
|
|
103
|
+
↓ Implements / Risk Source
|
|
104
|
+
Use Specification (Document)
|
|
105
|
+
↓ Relates
|
|
106
|
+
Use Scenario (Task, normal/abnormal)
|
|
107
|
+
↓ Risk Source
|
|
108
|
+
Hazard
|
|
109
|
+
↓ Mitigates
|
|
110
|
+
Mitigation Requirement (Requirement)
|
|
111
|
+
↓ Implements
|
|
112
|
+
SyRS (System Requirement)
|
|
113
|
+
↓ Implements
|
|
114
|
+
SRS (Requirement)
|
|
115
|
+
↓ Implements / Trace
|
|
116
|
+
Architecture → Detailed Design → Task (구현)
|
|
117
|
+
↓ Verifies
|
|
118
|
+
Test → Test Execution (V&V)
|
|
119
|
+
```
|
|
120
|
+
|
|
121
|
+
### 3.2 Consistency 평가 항목 (semantic)
|
|
122
|
+
|
|
123
|
+
| 평가 항목 | PASS | WARN | FAIL |
|
|
124
|
+
|---------|------|------|------|
|
|
125
|
+
| GSPR § N ↔ Hazard | GSPR 항목별 hazard 매핑 존재, severity 일관 | 일부 매핑 누락·정량값 불일치 | 매핑 자체 부재 또는 chain 단절 |
|
|
126
|
+
| Intended Use ↔ Use Scenario | 시나리오가 intended use 환자군/환경과 정합 | 일부 시나리오가 환자군 밖 | intended use 무시한 시나리오 또는 그 반대 |
|
|
127
|
+
| Hazard ↔ Mitigation (Risk Source / Mitigates 링크) | 각 Hazard에 1+ mitigation + residual risk 재평가 | mitigation은 있으나 residual risk 미평가 | hazard지만 mitigation 없음 (또는 chain 단절) |
|
|
128
|
+
| SyRS ↔ SRS | SyRS 1개당 SRS 1+ | 일부 SRS만 매핑 | SyRS 있음에도 SRS 없음 |
|
|
129
|
+
| Architecture ↔ Detailed Design | component 식별자 일치 | 약어·용어 차이 | 같은 기능인데 다른 이름 + link 없음 |
|
|
130
|
+
| V&V Test ↔ Requirement | 각 Requirement에 1+ Test | 일부 미검증 | 고위험 Requirement 검증 없음 |
|
|
131
|
+
| intended_use vs intended purpose | 의도된 사용 / 의도된 목적 용어 일관 | 혼용 | 한 문서 안에서 같은 의미 다른 단어 (정합성 ↓) |
|
|
132
|
+
|
|
133
|
+
### 3.3 Chain 평가 시 LLM 주의
|
|
134
|
+
|
|
135
|
+
- **링크 단절 (technical)** 발견 시 → layer-1 툴 결과로 권고 (`traceability_fix`로 일괄 보정 가능). LLM이 추측으로 링크 만들지 말 것.
|
|
136
|
+
- **내용 모순 (semantic)** 발견 시 → source 인용 필수. 동일 문서 내 모순이면 description line N 양쪽 인용, 다중 문서면 ticket key + field 명시.
|
|
137
|
+
- chain의 **각 hop을 직접 Read하지 않음** — 전체 description + links만 보고 hop-by-hop 추론. 깊은 graph traverse는 layer-1 툴(`traceability_check`)에 위임.
|
|
138
|
+
|
|
139
|
+
---
|
|
140
|
+
|
|
141
|
+
## 4. 용어 일관성 (terminology drift)
|
|
142
|
+
|
|
143
|
+
같은 의미에 다른 단어 사용은 **coverage 검증 정확도 ↓** + **gate reviewer 가독성 ↓**. LLM은 description 본문에서 다음 변종을 탐지.
|
|
144
|
+
|
|
145
|
+
| 표준 (canonical) | 흔한 변종 | 출처 |
|
|
146
|
+
|----------------|----------|------|
|
|
147
|
+
| intended purpose (의도된 목적) | intended use, intended usage | MDR Art.2(12) |
|
|
148
|
+
| intended patient population | target patient, intended patient group | MDR |
|
|
149
|
+
| residual risk | remaining risk | ISO 14971 |
|
|
150
|
+
| SOUP / OTS (Off-The-Shelf) | 3rd party component, commercial software | IEC 62304 §8 |
|
|
151
|
+
| SOUP anomaly | known bug, known issue | IEC 62304 |
|
|
152
|
+
| traceability | trace, linkage | IEC 62304 |
|
|
153
|
+
| Hazard-related use scenario | hazardous situation, use scenario | IEC 62366-1 |
|
|
154
|
+
| Post-Market Surveillance | PMS, post-market | MDR Chapter VII |
|
|
155
|
+
| FSCA (Field Safety Corrective Action) | field action, recall | MDR |
|
|
156
|
+
| benefit-risk | risk-benefit | MDR |
|
|
157
|
+
|
|
158
|
+
> 같은 문서·같은 chain 내에서 위 변종이 **혼용**되면 WARN. 표준 권장 단어를 **정본**으로 적시 권고.
|
|
159
|
+
|
|
160
|
+
---
|
|
161
|
+
|
|
162
|
+
## 5. 평가 깊이 가드 (severity 정의)
|
|
163
|
+
|
|
164
|
+
content/coverage evaluator는 verdict 외 **finding severity**도 명시. consumer가 triage하기 쉽도록.
|
|
165
|
+
|
|
166
|
+
| severity | 의미 | 예시 |
|
|
167
|
+
|----------|------|------|
|
|
168
|
+
| **critical** | gate 통과 불가. 즉시 보정 필요 | intended use와 hazard chain 단절 / soft SOUP 검증 없음 |
|
|
169
|
+
| **major** | gate 전 보정 권장 | placeholder 잔존 / risk 재평가 누락 / chain 일부 단절 |
|
|
170
|
+
| **minor** | 다음 PR에서 정리 | 용어 혼용 / 헤더 명칭 차이 / 약어 비통일 |
|
|
171
|
+
|
|
172
|
+
> critical ≥ 1이면 verdict ❌ BLOCK. 단 LLM 평가의 한계상 **soft 권고**이며 `mdr-regulatory-architect`의 hard verdict가 우선.
|
|
173
|
+
|
|
174
|
+
---
|
|
175
|
+
|
|
176
|
+
## 6. 평가 한계 (consumer에게 명시)
|
|
177
|
+
|
|
178
|
+
본 기준 적용 시 다음을 **pass 못함** (WARN → need human):
|
|
179
|
+
|
|
180
|
+
1. **의료 정확성** — hazard severity 정량값의 임상적 적절성은 LLM이 평가 불가 → `mdr-regulatory-architect` 또는 사람 reviewer 필요
|
|
181
|
+
2. **법적 책임** — gate 통과의 최종 책임은 사람 RA/QA에게 있음. LLM 평가가 "통과"여도 사람 승인 별도
|
|
182
|
+
3. **submodule 미체크아웃** — `vendor/dev-docs-templates/` 미체크아웃 시 템플릿 본문 직접 비교 불가. 평가 한정적
|
|
183
|
+
4. **첨부 PDF 컨텐츠** — PDF 본문 추출은 `pdf-text-extraction` 같은 layer-1 툴 추가 필요 (현재 미구현). 첨부 평가는 description만 가능
|
|
184
|
+
|
|
185
|
+
> 위 한계는 평가 결과 footer에 항상 명시 권장.
|
|
Binary file
|
|
Binary file
|
|
@@ -0,0 +1,342 @@
|
|
|
1
|
+
StartFontMetrics 4.1
|
|
2
|
+
Comment Copyright (c) 1989, 1990, 1991, 1993, 1997 Adobe Systems Incorporated. All Rights Reserved.
|
|
3
|
+
Comment Creation Date: Mon Jun 23 16:28:00 1997
|
|
4
|
+
Comment UniqueID 43048
|
|
5
|
+
Comment VMusage 41139 52164
|
|
6
|
+
FontName Courier-Bold
|
|
7
|
+
FullName Courier Bold
|
|
8
|
+
FamilyName Courier
|
|
9
|
+
Weight Bold
|
|
10
|
+
ItalicAngle 0
|
|
11
|
+
IsFixedPitch true
|
|
12
|
+
CharacterSet ExtendedRoman
|
|
13
|
+
FontBBox -113 -250 749 801
|
|
14
|
+
UnderlinePosition -100
|
|
15
|
+
UnderlineThickness 50
|
|
16
|
+
Version 003.000
|
|
17
|
+
Notice Copyright (c) 1989, 1990, 1991, 1993, 1997 Adobe Systems Incorporated. All Rights Reserved.
|
|
18
|
+
EncodingScheme AdobeStandardEncoding
|
|
19
|
+
CapHeight 562
|
|
20
|
+
XHeight 439
|
|
21
|
+
Ascender 629
|
|
22
|
+
Descender -157
|
|
23
|
+
StdHW 84
|
|
24
|
+
StdVW 106
|
|
25
|
+
StartCharMetrics 315
|
|
26
|
+
C 32 ; WX 600 ; N space ; B 0 0 0 0 ;
|
|
27
|
+
C 33 ; WX 600 ; N exclam ; B 202 -15 398 572 ;
|
|
28
|
+
C 34 ; WX 600 ; N quotedbl ; B 135 277 465 562 ;
|
|
29
|
+
C 35 ; WX 600 ; N numbersign ; B 56 -45 544 651 ;
|
|
30
|
+
C 36 ; WX 600 ; N dollar ; B 82 -126 519 666 ;
|
|
31
|
+
C 37 ; WX 600 ; N percent ; B 5 -15 595 616 ;
|
|
32
|
+
C 38 ; WX 600 ; N ampersand ; B 36 -15 546 543 ;
|
|
33
|
+
C 39 ; WX 600 ; N quoteright ; B 171 277 423 562 ;
|
|
34
|
+
C 40 ; WX 600 ; N parenleft ; B 219 -102 461 616 ;
|
|
35
|
+
C 41 ; WX 600 ; N parenright ; B 139 -102 381 616 ;
|
|
36
|
+
C 42 ; WX 600 ; N asterisk ; B 91 219 509 601 ;
|
|
37
|
+
C 43 ; WX 600 ; N plus ; B 71 39 529 478 ;
|
|
38
|
+
C 44 ; WX 600 ; N comma ; B 123 -111 393 174 ;
|
|
39
|
+
C 45 ; WX 600 ; N hyphen ; B 100 203 500 313 ;
|
|
40
|
+
C 46 ; WX 600 ; N period ; B 192 -15 408 171 ;
|
|
41
|
+
C 47 ; WX 600 ; N slash ; B 98 -77 502 626 ;
|
|
42
|
+
C 48 ; WX 600 ; N zero ; B 87 -15 513 616 ;
|
|
43
|
+
C 49 ; WX 600 ; N one ; B 81 0 539 616 ;
|
|
44
|
+
C 50 ; WX 600 ; N two ; B 61 0 499 616 ;
|
|
45
|
+
C 51 ; WX 600 ; N three ; B 63 -15 501 616 ;
|
|
46
|
+
C 52 ; WX 600 ; N four ; B 53 0 507 616 ;
|
|
47
|
+
C 53 ; WX 600 ; N five ; B 70 -15 521 601 ;
|
|
48
|
+
C 54 ; WX 600 ; N six ; B 90 -15 521 616 ;
|
|
49
|
+
C 55 ; WX 600 ; N seven ; B 55 0 494 601 ;
|
|
50
|
+
C 56 ; WX 600 ; N eight ; B 83 -15 517 616 ;
|
|
51
|
+
C 57 ; WX 600 ; N nine ; B 79 -15 510 616 ;
|
|
52
|
+
C 58 ; WX 600 ; N colon ; B 191 -15 407 425 ;
|
|
53
|
+
C 59 ; WX 600 ; N semicolon ; B 123 -111 408 425 ;
|
|
54
|
+
C 60 ; WX 600 ; N less ; B 66 15 523 501 ;
|
|
55
|
+
C 61 ; WX 600 ; N equal ; B 71 118 529 398 ;
|
|
56
|
+
C 62 ; WX 600 ; N greater ; B 77 15 534 501 ;
|
|
57
|
+
C 63 ; WX 600 ; N question ; B 98 -14 501 580 ;
|
|
58
|
+
C 64 ; WX 600 ; N at ; B 16 -15 584 616 ;
|
|
59
|
+
C 65 ; WX 600 ; N A ; B -9 0 609 562 ;
|
|
60
|
+
C 66 ; WX 600 ; N B ; B 30 0 573 562 ;
|
|
61
|
+
C 67 ; WX 600 ; N C ; B 22 -18 560 580 ;
|
|
62
|
+
C 68 ; WX 600 ; N D ; B 30 0 594 562 ;
|
|
63
|
+
C 69 ; WX 600 ; N E ; B 25 0 560 562 ;
|
|
64
|
+
C 70 ; WX 600 ; N F ; B 39 0 570 562 ;
|
|
65
|
+
C 71 ; WX 600 ; N G ; B 22 -18 594 580 ;
|
|
66
|
+
C 72 ; WX 600 ; N H ; B 20 0 580 562 ;
|
|
67
|
+
C 73 ; WX 600 ; N I ; B 77 0 523 562 ;
|
|
68
|
+
C 74 ; WX 600 ; N J ; B 37 -18 601 562 ;
|
|
69
|
+
C 75 ; WX 600 ; N K ; B 21 0 599 562 ;
|
|
70
|
+
C 76 ; WX 600 ; N L ; B 39 0 578 562 ;
|
|
71
|
+
C 77 ; WX 600 ; N M ; B -2 0 602 562 ;
|
|
72
|
+
C 78 ; WX 600 ; N N ; B 8 -12 610 562 ;
|
|
73
|
+
C 79 ; WX 600 ; N O ; B 22 -18 578 580 ;
|
|
74
|
+
C 80 ; WX 600 ; N P ; B 48 0 559 562 ;
|
|
75
|
+
C 81 ; WX 600 ; N Q ; B 32 -138 578 580 ;
|
|
76
|
+
C 82 ; WX 600 ; N R ; B 24 0 599 562 ;
|
|
77
|
+
C 83 ; WX 600 ; N S ; B 47 -22 553 582 ;
|
|
78
|
+
C 84 ; WX 600 ; N T ; B 21 0 579 562 ;
|
|
79
|
+
C 85 ; WX 600 ; N U ; B 4 -18 596 562 ;
|
|
80
|
+
C 86 ; WX 600 ; N V ; B -13 0 613 562 ;
|
|
81
|
+
C 87 ; WX 600 ; N W ; B -18 0 618 562 ;
|
|
82
|
+
C 88 ; WX 600 ; N X ; B 12 0 588 562 ;
|
|
83
|
+
C 89 ; WX 600 ; N Y ; B 12 0 589 562 ;
|
|
84
|
+
C 90 ; WX 600 ; N Z ; B 62 0 539 562 ;
|
|
85
|
+
C 91 ; WX 600 ; N bracketleft ; B 245 -102 475 616 ;
|
|
86
|
+
C 92 ; WX 600 ; N backslash ; B 99 -77 503 626 ;
|
|
87
|
+
C 93 ; WX 600 ; N bracketright ; B 125 -102 355 616 ;
|
|
88
|
+
C 94 ; WX 600 ; N asciicircum ; B 108 250 492 616 ;
|
|
89
|
+
C 95 ; WX 600 ; N underscore ; B 0 -125 600 -75 ;
|
|
90
|
+
C 96 ; WX 600 ; N quoteleft ; B 178 277 428 562 ;
|
|
91
|
+
C 97 ; WX 600 ; N a ; B 35 -15 570 454 ;
|
|
92
|
+
C 98 ; WX 600 ; N b ; B 0 -15 584 626 ;
|
|
93
|
+
C 99 ; WX 600 ; N c ; B 40 -15 545 459 ;
|
|
94
|
+
C 100 ; WX 600 ; N d ; B 20 -15 591 626 ;
|
|
95
|
+
C 101 ; WX 600 ; N e ; B 40 -15 563 454 ;
|
|
96
|
+
C 102 ; WX 600 ; N f ; B 83 0 547 626 ; L i fi ; L l fl ;
|
|
97
|
+
C 103 ; WX 600 ; N g ; B 30 -146 580 454 ;
|
|
98
|
+
C 104 ; WX 600 ; N h ; B 5 0 592 626 ;
|
|
99
|
+
C 105 ; WX 600 ; N i ; B 77 0 523 658 ;
|
|
100
|
+
C 106 ; WX 600 ; N j ; B 63 -146 440 658 ;
|
|
101
|
+
C 107 ; WX 600 ; N k ; B 20 0 585 626 ;
|
|
102
|
+
C 108 ; WX 600 ; N l ; B 77 0 523 626 ;
|
|
103
|
+
C 109 ; WX 600 ; N m ; B -22 0 626 454 ;
|
|
104
|
+
C 110 ; WX 600 ; N n ; B 18 0 592 454 ;
|
|
105
|
+
C 111 ; WX 600 ; N o ; B 30 -15 570 454 ;
|
|
106
|
+
C 112 ; WX 600 ; N p ; B -1 -142 570 454 ;
|
|
107
|
+
C 113 ; WX 600 ; N q ; B 20 -142 591 454 ;
|
|
108
|
+
C 114 ; WX 600 ; N r ; B 47 0 580 454 ;
|
|
109
|
+
C 115 ; WX 600 ; N s ; B 68 -17 535 459 ;
|
|
110
|
+
C 116 ; WX 600 ; N t ; B 47 -15 532 562 ;
|
|
111
|
+
C 117 ; WX 600 ; N u ; B -1 -15 569 439 ;
|
|
112
|
+
C 118 ; WX 600 ; N v ; B -1 0 601 439 ;
|
|
113
|
+
C 119 ; WX 600 ; N w ; B -18 0 618 439 ;
|
|
114
|
+
C 120 ; WX 600 ; N x ; B 6 0 594 439 ;
|
|
115
|
+
C 121 ; WX 600 ; N y ; B -4 -142 601 439 ;
|
|
116
|
+
C 122 ; WX 600 ; N z ; B 81 0 520 439 ;
|
|
117
|
+
C 123 ; WX 600 ; N braceleft ; B 160 -102 464 616 ;
|
|
118
|
+
C 124 ; WX 600 ; N bar ; B 255 -250 345 750 ;
|
|
119
|
+
C 125 ; WX 600 ; N braceright ; B 136 -102 440 616 ;
|
|
120
|
+
C 126 ; WX 600 ; N asciitilde ; B 71 153 530 356 ;
|
|
121
|
+
C 161 ; WX 600 ; N exclamdown ; B 202 -146 398 449 ;
|
|
122
|
+
C 162 ; WX 600 ; N cent ; B 66 -49 518 614 ;
|
|
123
|
+
C 163 ; WX 600 ; N sterling ; B 72 -28 558 611 ;
|
|
124
|
+
C 164 ; WX 600 ; N fraction ; B 25 -60 576 661 ;
|
|
125
|
+
C 165 ; WX 600 ; N yen ; B 10 0 590 562 ;
|
|
126
|
+
C 166 ; WX 600 ; N florin ; B -30 -131 572 616 ;
|
|
127
|
+
C 167 ; WX 600 ; N section ; B 83 -70 517 580 ;
|
|
128
|
+
C 168 ; WX 600 ; N currency ; B 54 49 546 517 ;
|
|
129
|
+
C 169 ; WX 600 ; N quotesingle ; B 227 277 373 562 ;
|
|
130
|
+
C 170 ; WX 600 ; N quotedblleft ; B 71 277 535 562 ;
|
|
131
|
+
C 171 ; WX 600 ; N guillemotleft ; B 8 70 553 446 ;
|
|
132
|
+
C 172 ; WX 600 ; N guilsinglleft ; B 141 70 459 446 ;
|
|
133
|
+
C 173 ; WX 600 ; N guilsinglright ; B 141 70 459 446 ;
|
|
134
|
+
C 174 ; WX 600 ; N fi ; B 12 0 593 626 ;
|
|
135
|
+
C 175 ; WX 600 ; N fl ; B 12 0 593 626 ;
|
|
136
|
+
C 177 ; WX 600 ; N endash ; B 65 203 535 313 ;
|
|
137
|
+
C 178 ; WX 600 ; N dagger ; B 106 -70 494 580 ;
|
|
138
|
+
C 179 ; WX 600 ; N daggerdbl ; B 106 -70 494 580 ;
|
|
139
|
+
C 180 ; WX 600 ; N periodcentered ; B 196 165 404 351 ;
|
|
140
|
+
C 182 ; WX 600 ; N paragraph ; B 6 -70 576 580 ;
|
|
141
|
+
C 183 ; WX 600 ; N bullet ; B 140 132 460 430 ;
|
|
142
|
+
C 184 ; WX 600 ; N quotesinglbase ; B 175 -142 427 143 ;
|
|
143
|
+
C 185 ; WX 600 ; N quotedblbase ; B 65 -142 529 143 ;
|
|
144
|
+
C 186 ; WX 600 ; N quotedblright ; B 61 277 525 562 ;
|
|
145
|
+
C 187 ; WX 600 ; N guillemotright ; B 47 70 592 446 ;
|
|
146
|
+
C 188 ; WX 600 ; N ellipsis ; B 26 -15 574 116 ;
|
|
147
|
+
C 189 ; WX 600 ; N perthousand ; B -113 -15 713 616 ;
|
|
148
|
+
C 191 ; WX 600 ; N questiondown ; B 99 -146 502 449 ;
|
|
149
|
+
C 193 ; WX 600 ; N grave ; B 132 508 395 661 ;
|
|
150
|
+
C 194 ; WX 600 ; N acute ; B 205 508 468 661 ;
|
|
151
|
+
C 195 ; WX 600 ; N circumflex ; B 103 483 497 657 ;
|
|
152
|
+
C 196 ; WX 600 ; N tilde ; B 89 493 512 636 ;
|
|
153
|
+
C 197 ; WX 600 ; N macron ; B 88 505 512 585 ;
|
|
154
|
+
C 198 ; WX 600 ; N breve ; B 83 468 517 631 ;
|
|
155
|
+
C 199 ; WX 600 ; N dotaccent ; B 230 498 370 638 ;
|
|
156
|
+
C 200 ; WX 600 ; N dieresis ; B 128 498 472 638 ;
|
|
157
|
+
C 202 ; WX 600 ; N ring ; B 198 481 402 678 ;
|
|
158
|
+
C 203 ; WX 600 ; N cedilla ; B 205 -206 387 0 ;
|
|
159
|
+
C 205 ; WX 600 ; N hungarumlaut ; B 68 488 588 661 ;
|
|
160
|
+
C 206 ; WX 600 ; N ogonek ; B 169 -199 400 0 ;
|
|
161
|
+
C 207 ; WX 600 ; N caron ; B 103 493 497 667 ;
|
|
162
|
+
C 208 ; WX 600 ; N emdash ; B -10 203 610 313 ;
|
|
163
|
+
C 225 ; WX 600 ; N AE ; B -29 0 602 562 ;
|
|
164
|
+
C 227 ; WX 600 ; N ordfeminine ; B 147 196 453 580 ;
|
|
165
|
+
C 232 ; WX 600 ; N Lslash ; B 39 0 578 562 ;
|
|
166
|
+
C 233 ; WX 600 ; N Oslash ; B 22 -22 578 584 ;
|
|
167
|
+
C 234 ; WX 600 ; N OE ; B -25 0 595 562 ;
|
|
168
|
+
C 235 ; WX 600 ; N ordmasculine ; B 147 196 453 580 ;
|
|
169
|
+
C 241 ; WX 600 ; N ae ; B -4 -15 601 454 ;
|
|
170
|
+
C 245 ; WX 600 ; N dotlessi ; B 77 0 523 439 ;
|
|
171
|
+
C 248 ; WX 600 ; N lslash ; B 77 0 523 626 ;
|
|
172
|
+
C 249 ; WX 600 ; N oslash ; B 30 -24 570 463 ;
|
|
173
|
+
C 250 ; WX 600 ; N oe ; B -18 -15 611 454 ;
|
|
174
|
+
C 251 ; WX 600 ; N germandbls ; B 22 -15 596 626 ;
|
|
175
|
+
C -1 ; WX 600 ; N Idieresis ; B 77 0 523 761 ;
|
|
176
|
+
C -1 ; WX 600 ; N eacute ; B 40 -15 563 661 ;
|
|
177
|
+
C -1 ; WX 600 ; N abreve ; B 35 -15 570 661 ;
|
|
178
|
+
C -1 ; WX 600 ; N uhungarumlaut ; B -1 -15 628 661 ;
|
|
179
|
+
C -1 ; WX 600 ; N ecaron ; B 40 -15 563 667 ;
|
|
180
|
+
C -1 ; WX 600 ; N Ydieresis ; B 12 0 589 761 ;
|
|
181
|
+
C -1 ; WX 600 ; N divide ; B 71 16 529 500 ;
|
|
182
|
+
C -1 ; WX 600 ; N Yacute ; B 12 0 589 784 ;
|
|
183
|
+
C -1 ; WX 600 ; N Acircumflex ; B -9 0 609 780 ;
|
|
184
|
+
C -1 ; WX 600 ; N aacute ; B 35 -15 570 661 ;
|
|
185
|
+
C -1 ; WX 600 ; N Ucircumflex ; B 4 -18 596 780 ;
|
|
186
|
+
C -1 ; WX 600 ; N yacute ; B -4 -142 601 661 ;
|
|
187
|
+
C -1 ; WX 600 ; N scommaaccent ; B 68 -250 535 459 ;
|
|
188
|
+
C -1 ; WX 600 ; N ecircumflex ; B 40 -15 563 657 ;
|
|
189
|
+
C -1 ; WX 600 ; N Uring ; B 4 -18 596 801 ;
|
|
190
|
+
C -1 ; WX 600 ; N Udieresis ; B 4 -18 596 761 ;
|
|
191
|
+
C -1 ; WX 600 ; N aogonek ; B 35 -199 586 454 ;
|
|
192
|
+
C -1 ; WX 600 ; N Uacute ; B 4 -18 596 784 ;
|
|
193
|
+
C -1 ; WX 600 ; N uogonek ; B -1 -199 585 439 ;
|
|
194
|
+
C -1 ; WX 600 ; N Edieresis ; B 25 0 560 761 ;
|
|
195
|
+
C -1 ; WX 600 ; N Dcroat ; B 30 0 594 562 ;
|
|
196
|
+
C -1 ; WX 600 ; N commaaccent ; B 205 -250 397 -57 ;
|
|
197
|
+
C -1 ; WX 600 ; N copyright ; B 0 -18 600 580 ;
|
|
198
|
+
C -1 ; WX 600 ; N Emacron ; B 25 0 560 708 ;
|
|
199
|
+
C -1 ; WX 600 ; N ccaron ; B 40 -15 545 667 ;
|
|
200
|
+
C -1 ; WX 600 ; N aring ; B 35 -15 570 678 ;
|
|
201
|
+
C -1 ; WX 600 ; N Ncommaaccent ; B 8 -250 610 562 ;
|
|
202
|
+
C -1 ; WX 600 ; N lacute ; B 77 0 523 801 ;
|
|
203
|
+
C -1 ; WX 600 ; N agrave ; B 35 -15 570 661 ;
|
|
204
|
+
C -1 ; WX 600 ; N Tcommaaccent ; B 21 -250 579 562 ;
|
|
205
|
+
C -1 ; WX 600 ; N Cacute ; B 22 -18 560 784 ;
|
|
206
|
+
C -1 ; WX 600 ; N atilde ; B 35 -15 570 636 ;
|
|
207
|
+
C -1 ; WX 600 ; N Edotaccent ; B 25 0 560 761 ;
|
|
208
|
+
C -1 ; WX 600 ; N scaron ; B 68 -17 535 667 ;
|
|
209
|
+
C -1 ; WX 600 ; N scedilla ; B 68 -206 535 459 ;
|
|
210
|
+
C -1 ; WX 600 ; N iacute ; B 77 0 523 661 ;
|
|
211
|
+
C -1 ; WX 600 ; N lozenge ; B 66 0 534 740 ;
|
|
212
|
+
C -1 ; WX 600 ; N Rcaron ; B 24 0 599 790 ;
|
|
213
|
+
C -1 ; WX 600 ; N Gcommaaccent ; B 22 -250 594 580 ;
|
|
214
|
+
C -1 ; WX 600 ; N ucircumflex ; B -1 -15 569 657 ;
|
|
215
|
+
C -1 ; WX 600 ; N acircumflex ; B 35 -15 570 657 ;
|
|
216
|
+
C -1 ; WX 600 ; N Amacron ; B -9 0 609 708 ;
|
|
217
|
+
C -1 ; WX 600 ; N rcaron ; B 47 0 580 667 ;
|
|
218
|
+
C -1 ; WX 600 ; N ccedilla ; B 40 -206 545 459 ;
|
|
219
|
+
C -1 ; WX 600 ; N Zdotaccent ; B 62 0 539 761 ;
|
|
220
|
+
C -1 ; WX 600 ; N Thorn ; B 48 0 557 562 ;
|
|
221
|
+
C -1 ; WX 600 ; N Omacron ; B 22 -18 578 708 ;
|
|
222
|
+
C -1 ; WX 600 ; N Racute ; B 24 0 599 784 ;
|
|
223
|
+
C -1 ; WX 600 ; N Sacute ; B 47 -22 553 784 ;
|
|
224
|
+
C -1 ; WX 600 ; N dcaron ; B 20 -15 727 626 ;
|
|
225
|
+
C -1 ; WX 600 ; N Umacron ; B 4 -18 596 708 ;
|
|
226
|
+
C -1 ; WX 600 ; N uring ; B -1 -15 569 678 ;
|
|
227
|
+
C -1 ; WX 600 ; N threesuperior ; B 138 222 433 616 ;
|
|
228
|
+
C -1 ; WX 600 ; N Ograve ; B 22 -18 578 784 ;
|
|
229
|
+
C -1 ; WX 600 ; N Agrave ; B -9 0 609 784 ;
|
|
230
|
+
C -1 ; WX 600 ; N Abreve ; B -9 0 609 784 ;
|
|
231
|
+
C -1 ; WX 600 ; N multiply ; B 81 39 520 478 ;
|
|
232
|
+
C -1 ; WX 600 ; N uacute ; B -1 -15 569 661 ;
|
|
233
|
+
C -1 ; WX 600 ; N Tcaron ; B 21 0 579 790 ;
|
|
234
|
+
C -1 ; WX 600 ; N partialdiff ; B 63 -38 537 728 ;
|
|
235
|
+
C -1 ; WX 600 ; N ydieresis ; B -4 -142 601 638 ;
|
|
236
|
+
C -1 ; WX 600 ; N Nacute ; B 8 -12 610 784 ;
|
|
237
|
+
C -1 ; WX 600 ; N icircumflex ; B 73 0 523 657 ;
|
|
238
|
+
C -1 ; WX 600 ; N Ecircumflex ; B 25 0 560 780 ;
|
|
239
|
+
C -1 ; WX 600 ; N adieresis ; B 35 -15 570 638 ;
|
|
240
|
+
C -1 ; WX 600 ; N edieresis ; B 40 -15 563 638 ;
|
|
241
|
+
C -1 ; WX 600 ; N cacute ; B 40 -15 545 661 ;
|
|
242
|
+
C -1 ; WX 600 ; N nacute ; B 18 0 592 661 ;
|
|
243
|
+
C -1 ; WX 600 ; N umacron ; B -1 -15 569 585 ;
|
|
244
|
+
C -1 ; WX 600 ; N Ncaron ; B 8 -12 610 790 ;
|
|
245
|
+
C -1 ; WX 600 ; N Iacute ; B 77 0 523 784 ;
|
|
246
|
+
C -1 ; WX 600 ; N plusminus ; B 71 24 529 515 ;
|
|
247
|
+
C -1 ; WX 600 ; N brokenbar ; B 255 -175 345 675 ;
|
|
248
|
+
C -1 ; WX 600 ; N registered ; B 0 -18 600 580 ;
|
|
249
|
+
C -1 ; WX 600 ; N Gbreve ; B 22 -18 594 784 ;
|
|
250
|
+
C -1 ; WX 600 ; N Idotaccent ; B 77 0 523 761 ;
|
|
251
|
+
C -1 ; WX 600 ; N summation ; B 15 -10 586 706 ;
|
|
252
|
+
C -1 ; WX 600 ; N Egrave ; B 25 0 560 784 ;
|
|
253
|
+
C -1 ; WX 600 ; N racute ; B 47 0 580 661 ;
|
|
254
|
+
C -1 ; WX 600 ; N omacron ; B 30 -15 570 585 ;
|
|
255
|
+
C -1 ; WX 600 ; N Zacute ; B 62 0 539 784 ;
|
|
256
|
+
C -1 ; WX 600 ; N Zcaron ; B 62 0 539 790 ;
|
|
257
|
+
C -1 ; WX 600 ; N greaterequal ; B 26 0 523 696 ;
|
|
258
|
+
C -1 ; WX 600 ; N Eth ; B 30 0 594 562 ;
|
|
259
|
+
C -1 ; WX 600 ; N Ccedilla ; B 22 -206 560 580 ;
|
|
260
|
+
C -1 ; WX 600 ; N lcommaaccent ; B 77 -250 523 626 ;
|
|
261
|
+
C -1 ; WX 600 ; N tcaron ; B 47 -15 532 703 ;
|
|
262
|
+
C -1 ; WX 600 ; N eogonek ; B 40 -199 563 454 ;
|
|
263
|
+
C -1 ; WX 600 ; N Uogonek ; B 4 -199 596 562 ;
|
|
264
|
+
C -1 ; WX 600 ; N Aacute ; B -9 0 609 784 ;
|
|
265
|
+
C -1 ; WX 600 ; N Adieresis ; B -9 0 609 761 ;
|
|
266
|
+
C -1 ; WX 600 ; N egrave ; B 40 -15 563 661 ;
|
|
267
|
+
C -1 ; WX 600 ; N zacute ; B 81 0 520 661 ;
|
|
268
|
+
C -1 ; WX 600 ; N iogonek ; B 77 -199 523 658 ;
|
|
269
|
+
C -1 ; WX 600 ; N Oacute ; B 22 -18 578 784 ;
|
|
270
|
+
C -1 ; WX 600 ; N oacute ; B 30 -15 570 661 ;
|
|
271
|
+
C -1 ; WX 600 ; N amacron ; B 35 -15 570 585 ;
|
|
272
|
+
C -1 ; WX 600 ; N sacute ; B 68 -17 535 661 ;
|
|
273
|
+
C -1 ; WX 600 ; N idieresis ; B 77 0 523 618 ;
|
|
274
|
+
C -1 ; WX 600 ; N Ocircumflex ; B 22 -18 578 780 ;
|
|
275
|
+
C -1 ; WX 600 ; N Ugrave ; B 4 -18 596 784 ;
|
|
276
|
+
C -1 ; WX 600 ; N Delta ; B 6 0 594 688 ;
|
|
277
|
+
C -1 ; WX 600 ; N thorn ; B -14 -142 570 626 ;
|
|
278
|
+
C -1 ; WX 600 ; N twosuperior ; B 143 230 436 616 ;
|
|
279
|
+
C -1 ; WX 600 ; N Odieresis ; B 22 -18 578 761 ;
|
|
280
|
+
C -1 ; WX 600 ; N mu ; B -1 -142 569 439 ;
|
|
281
|
+
C -1 ; WX 600 ; N igrave ; B 77 0 523 661 ;
|
|
282
|
+
C -1 ; WX 600 ; N ohungarumlaut ; B 30 -15 668 661 ;
|
|
283
|
+
C -1 ; WX 600 ; N Eogonek ; B 25 -199 576 562 ;
|
|
284
|
+
C -1 ; WX 600 ; N dcroat ; B 20 -15 591 626 ;
|
|
285
|
+
C -1 ; WX 600 ; N threequarters ; B -47 -60 648 661 ;
|
|
286
|
+
C -1 ; WX 600 ; N Scedilla ; B 47 -206 553 582 ;
|
|
287
|
+
C -1 ; WX 600 ; N lcaron ; B 77 0 597 626 ;
|
|
288
|
+
C -1 ; WX 600 ; N Kcommaaccent ; B 21 -250 599 562 ;
|
|
289
|
+
C -1 ; WX 600 ; N Lacute ; B 39 0 578 784 ;
|
|
290
|
+
C -1 ; WX 600 ; N trademark ; B -9 230 749 562 ;
|
|
291
|
+
C -1 ; WX 600 ; N edotaccent ; B 40 -15 563 638 ;
|
|
292
|
+
C -1 ; WX 600 ; N Igrave ; B 77 0 523 784 ;
|
|
293
|
+
C -1 ; WX 600 ; N Imacron ; B 77 0 523 708 ;
|
|
294
|
+
C -1 ; WX 600 ; N Lcaron ; B 39 0 637 562 ;
|
|
295
|
+
C -1 ; WX 600 ; N onehalf ; B -47 -60 648 661 ;
|
|
296
|
+
C -1 ; WX 600 ; N lessequal ; B 26 0 523 696 ;
|
|
297
|
+
C -1 ; WX 600 ; N ocircumflex ; B 30 -15 570 657 ;
|
|
298
|
+
C -1 ; WX 600 ; N ntilde ; B 18 0 592 636 ;
|
|
299
|
+
C -1 ; WX 600 ; N Uhungarumlaut ; B 4 -18 638 784 ;
|
|
300
|
+
C -1 ; WX 600 ; N Eacute ; B 25 0 560 784 ;
|
|
301
|
+
C -1 ; WX 600 ; N emacron ; B 40 -15 563 585 ;
|
|
302
|
+
C -1 ; WX 600 ; N gbreve ; B 30 -146 580 661 ;
|
|
303
|
+
C -1 ; WX 600 ; N onequarter ; B -56 -60 656 661 ;
|
|
304
|
+
C -1 ; WX 600 ; N Scaron ; B 47 -22 553 790 ;
|
|
305
|
+
C -1 ; WX 600 ; N Scommaaccent ; B 47 -250 553 582 ;
|
|
306
|
+
C -1 ; WX 600 ; N Ohungarumlaut ; B 22 -18 628 784 ;
|
|
307
|
+
C -1 ; WX 600 ; N degree ; B 86 243 474 616 ;
|
|
308
|
+
C -1 ; WX 600 ; N ograve ; B 30 -15 570 661 ;
|
|
309
|
+
C -1 ; WX 600 ; N Ccaron ; B 22 -18 560 790 ;
|
|
310
|
+
C -1 ; WX 600 ; N ugrave ; B -1 -15 569 661 ;
|
|
311
|
+
C -1 ; WX 600 ; N radical ; B -19 -104 473 778 ;
|
|
312
|
+
C -1 ; WX 600 ; N Dcaron ; B 30 0 594 790 ;
|
|
313
|
+
C -1 ; WX 600 ; N rcommaaccent ; B 47 -250 580 454 ;
|
|
314
|
+
C -1 ; WX 600 ; N Ntilde ; B 8 -12 610 759 ;
|
|
315
|
+
C -1 ; WX 600 ; N otilde ; B 30 -15 570 636 ;
|
|
316
|
+
C -1 ; WX 600 ; N Rcommaaccent ; B 24 -250 599 562 ;
|
|
317
|
+
C -1 ; WX 600 ; N Lcommaaccent ; B 39 -250 578 562 ;
|
|
318
|
+
C -1 ; WX 600 ; N Atilde ; B -9 0 609 759 ;
|
|
319
|
+
C -1 ; WX 600 ; N Aogonek ; B -9 -199 625 562 ;
|
|
320
|
+
C -1 ; WX 600 ; N Aring ; B -9 0 609 801 ;
|
|
321
|
+
C -1 ; WX 600 ; N Otilde ; B 22 -18 578 759 ;
|
|
322
|
+
C -1 ; WX 600 ; N zdotaccent ; B 81 0 520 638 ;
|
|
323
|
+
C -1 ; WX 600 ; N Ecaron ; B 25 0 560 790 ;
|
|
324
|
+
C -1 ; WX 600 ; N Iogonek ; B 77 -199 523 562 ;
|
|
325
|
+
C -1 ; WX 600 ; N kcommaaccent ; B 20 -250 585 626 ;
|
|
326
|
+
C -1 ; WX 600 ; N minus ; B 71 203 529 313 ;
|
|
327
|
+
C -1 ; WX 600 ; N Icircumflex ; B 77 0 523 780 ;
|
|
328
|
+
C -1 ; WX 600 ; N ncaron ; B 18 0 592 667 ;
|
|
329
|
+
C -1 ; WX 600 ; N tcommaaccent ; B 47 -250 532 562 ;
|
|
330
|
+
C -1 ; WX 600 ; N logicalnot ; B 71 103 529 413 ;
|
|
331
|
+
C -1 ; WX 600 ; N odieresis ; B 30 -15 570 638 ;
|
|
332
|
+
C -1 ; WX 600 ; N udieresis ; B -1 -15 569 638 ;
|
|
333
|
+
C -1 ; WX 600 ; N notequal ; B 12 -47 537 563 ;
|
|
334
|
+
C -1 ; WX 600 ; N gcommaaccent ; B 30 -146 580 714 ;
|
|
335
|
+
C -1 ; WX 600 ; N eth ; B 58 -27 543 626 ;
|
|
336
|
+
C -1 ; WX 600 ; N zcaron ; B 81 0 520 667 ;
|
|
337
|
+
C -1 ; WX 600 ; N ncommaaccent ; B 18 -250 592 454 ;
|
|
338
|
+
C -1 ; WX 600 ; N onesuperior ; B 153 230 447 616 ;
|
|
339
|
+
C -1 ; WX 600 ; N imacron ; B 77 0 523 585 ;
|
|
340
|
+
C -1 ; WX 600 ; N Euro ; B 0 0 0 0 ;
|
|
341
|
+
EndCharMetrics
|
|
342
|
+
EndFontMetrics
|